SCHEMBL3852018

SCHEMBL3852018

O=C(Nc1nccs1)c1ccc(-c2ncnc3ccc(Br)cc23)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 13/20 0.55
NPC1 O15118 12/20 0.55
MEN1 O00255 6/20 0.55
KMT2A Q03164 6/20 0.55
ALDH1A1 P00352 6/20 0.49
HPGD P15428 4/20 0.49
POLB P06746 2/20 0.43
MAPT P10636 2/20 0.43
ESR2 Q92731 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SMN1; SMN2 Q16637 5/20 0.42
KDM4E B2RXH2 2/20 0.42
PKM P14618 1/20 0.42
XBP1 P17861 1/20 0.42
ALOX12 P18054 1/20 0.42
HTT P42858 1/20 0.42
KLF5 Q13887 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847683 0.79 RPS6KB2 (0.50) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL3854353 0.76 KMT2A (0.38) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL3847485 0.70 SMN1; SMN2 (0.54) NPC1MEN1KMT2AALDH1A1HPGD
SCHEMBL16688492 0.69 RAB9A (0.76) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL3847128 0.69 SMN1; SMN2 (0.44) NPC1MEN1KMT2AALDH1A1HPGD
SCHEMBL3849285 0.68 SMN1; SMN2 (0.46) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL2657441 0.67 NPC1 (1.00) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL330586 0.67 KCNMA1 (0.71) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL3851528 0.66 SMN1; SMN2 (0.47) NPC1MEN1KMT2AALDH1A1HPGD
SCHEMBL3845623 0.66 SMN1; SMN2 (0.44) NPC1MEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed